Hypertension in developing nations in sub-Saharan Africa

Journal of Human Hypertension

Volumn 14, Issue 10-11, 2000, Pages 739-747

  Seedat, Y K ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

Cardiovascular disease; Developing countries; Sub Saharan Africa

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; CLONIDINE; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; HYDROCHLOROTHIAZIDE; IRBESARTAN; LABETALOL; LOSARTAN; NIFEDIPINE; PRAZOSIN; PROPANOL; RAUWOLFIA EXTRACT; RESERPINE; SOTALOL; THIAZIDE DIURETIC AGENT; VALSARTAN; VERAPAMIL;

AFRICA SOUTH OF THE SAHARA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG COST; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; NOSE CONGESTION; POPULATION RISK; RESOURCE ALLOCATION; REVIEW; SUSTAINED RELEASE PREPARATION;

EID: 0033765391     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001059     Document Type: Review

References (83)

1. Hypertension in developing countries
2. World epidemiology of hypertension in blacks
3. Race, environment and blood pressure: The South African experience
4. Blood pressure distribution in a rural Ghanaian population
5. Arterial blood pressures and hypertension in a rural Nigerian community
6. Arterial hypertension in rural societies
7. Blood pressure in Bushmen of the Kalahari Desert
8. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: Data from the health examinations surveys, 1960 to 1991
9. Hypertension surveys in the developing world. Lessons from the Egyptian National Project (NHP)
10. Assessing the burden of mortality from cardiovascular disease
11. The challenge of hypertension and atherosclerotic cardiovascular disease in economically developing countries
12. Cardiovascular disease
13. The epidemiologic transition: A key of the epidemiology of population change
14. Emerging epidemic of cardiovascular disease in developing countries
15. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion
16. The public health impact of globalisation of food trade
17. Foetal origins of coronary heart disease
18. Growth in utero and serum cholesterol concentration in adult life
19. Growth in utero, adult blood pressure and arterial compliance
20. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature
21. Genetic and ethnic influences on the distribution of sodium and potassium in normotensive and hypertensive subjects
22. Racial differences in intact erythrocyte ion transport
23. Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents
24. A study of urinary and intracellular sodium and potassium, renin, aldosterone and hypertension in blacks and Indians in Natal
25. Familial aggregation of urinary kallikrein concentration in childhood: Relation to blood pressure, race and urinary electrolytes
26. Hypertension in black populations
27. Creatinine clearance, electrolytes, and plasma renin activity related to blood pressure of white and black children - The Bogalusa Study
28. Childhood familial and racial differences in physiologic and biochemical factors related to hypertension
29. Heritability of blood pressure
30. A study of urinary sodium and potassium excretion rates among urban and rural Zulus and Indians
31. Sodium sensitivity and resistance in normotensive humans
32. The salivary sodium/potassium ratio in hypertension: Relation to race and plasma renin activity
33. Spot urinary concentrations and 24 hour urinary excretion
34. The renin-angiotensin system and blood pressure: Differences between blacks and whites
35. Mortality differences between black and white men in the USA: Contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial
36. Factors influencing arterial pressure in the general population in Jamaica
37. Prevalence of hypertension in the urban and rural Zulu
38. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension
39. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects
40. Use of diuretic agents in obese or black patients with systemic hypertension
41. Blood pressure and echocardiographic measures in children: The Bogalusa Heart Study
42. Contrast in cardiac anatomy and function between black and white patients with hypertension
43. Ambulatory blood pressure and risk factors for coronary heart disease in black and Indian medical students
44. Myocardial infarction in the African hypertensive patient
45. Coronary heart disease in blacks
46. Study of risk factors leading to coronary heart disease in urban Zulus
47. Veterans Administration Cooperative Study on Anti-hypertensive Agents: Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. 1. Results of short-term titration with emphasis on racial differences in response
48. Responses to captopril and hydrochlorothiazide in black patients with hypertension
49. Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in black and Indian hypertensive patients
50. Varying responses to hypotensive agents in different racial groups: Black versus white differences
51. Renin classification for diuretic and beta blocker treatment of black hypertensive patients
52. Does a renal vasodilator system mediate racial differences in essential hypertension?
53. Labetalol hydrochloride in the treatment of black and Indian hypertensive patients
54. Efficacy of carvedilol in hypertensive black patients: A pilot study
55. Monotherapy with nifedipine for essential hypertension in adult blacks
56. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension
57. Treatment of hypertension with verapamil
58. Intracellular sodium and the response to nitrendipine or atenolol in African blacks
59. Treating hypertension in black compared with white non-insulin dependent diabetics: A double-blind trial of verapamil and metoprolol
60. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
61. Do angiotensin-converting enzyme inhibitors work in black hypertensives? A review
62. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension
63. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension
64. Controlled trial of Losarton given concomitantly with different doses of hydrochlorothiazide in hypertensive patients
65. United States Renal Data System 1992 Annual Data Report. Analytical Methods: Technical notes
66. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials
67. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
68. Randomized controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure
69. The stepped-care approach to the treatment of hypertension in black patients
70. Angiotensin converting enzyme inhibition in clinical practice. Choice of initial treatment
71. Pharmacologic management of systemic hypertension in blacks
72. Report of the Joint National Committee on Detection, Evaluation of High Blood Pressure: A cooperative study
73. Drug treatment for the hypertensive black patient
74. Perspective of hypertension in black patients; black vs white differences
75. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and treatment of High Blood Pressure
76. 1999 World Health Organisation - International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee
77. Cardiovascular disease in India